BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 31175644)

  • 21. Cellular Reprogramming Allows Generation of Autologous Hematopoietic Progenitors From AML Patients That Are Devoid of Patient-Specific Genomic Aberrations.
    Salci KR; Lee JH; Laronde S; Dingwall S; Kushwah R; Fiebig-Comyn A; Leber B; Foley R; Dal Cin A; Bhatia M
    Stem Cells; 2015 Jun; 33(6):1839-49. PubMed ID: 25764124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fetal sheep support the development of hematopoietic cells in vivo from human induced pluripotent stem cells.
    Abe T; Uosaki H; Shibata H; Hara H; Sarentonglaga B; Nagao Y; Hanazono Y
    Exp Hematol; 2021 Mar; 95():46-57.e8. PubMed ID: 33395577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. On signaling pathways: hematopoietic stem cell specification from hemogenic endothelium.
    Long Y; Huang H
    Sci China Life Sci; 2015 Dec; 58(12):1256-61. PubMed ID: 26612042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of hematopoietic stem and progenitor cells from human pluripotent stem cells.
    Chen T; Wang F; Wu M; Wang ZZ
    J Cell Biochem; 2015 Jul; 116(7):1179-89. PubMed ID: 25740540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Robust generation of erythroid and multilineage hematopoietic progenitors from human iPSCs using a scalable monolayer culture system.
    Ruiz JP; Chen G; Haro Mora JJ; Keyvanfar K; Liu C; Zou J; Beers J; Bloomer H; Qanash H; Uchida N; Tisdale JF; Boehm M; Larochelle A
    Stem Cell Res; 2019 Dec; 41():101600. PubMed ID: 31710911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The hemogenic endothelium: a critical source for the generation of PSC-derived hematopoietic stem and progenitor cells.
    Lange L; Morgan M; Schambach A
    Cell Mol Life Sci; 2021 May; 78(9):4143-4160. PubMed ID: 33559689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell type of origin influences iPSC generation and differentiation to cells of the hematoendothelial lineage.
    Phetfong J; Supokawej A; Wattanapanitch M; Kheolamai P; U-Pratya Y; Issaragrisil S
    Cell Tissue Res; 2016 Jul; 365(1):101-12. PubMed ID: 26893154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of CD34 Fluorescent Reporter Human Induced Pluripotent Stem Cells for Monitoring Hematopoietic Differentiation.
    Husa AM; Strobl MR; Strajeriu A; Wieser M; Strehl S; Fortschegger K
    Stem Cells Dev; 2018 Oct; 27(19):1376-1384. PubMed ID: 30009677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved hematopoietic differentiation efficiency of gene-corrected beta-thalassemia induced pluripotent stem cells by CRISPR/Cas9 system.
    Song B; Fan Y; He W; Zhu D; Niu X; Wang D; Ou Z; Luo M; Sun X
    Stem Cells Dev; 2015 May; 24(9):1053-65. PubMed ID: 25517294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation, Expansion, and Differentiation of Human Induced Pluripotent Stem Cells (hiPSCs) Derived From the Umbilical Cords of Newborns.
    Song RS; Carroll JM; Acevedo L; Wu D; Liu Y; Snyder EY
    Curr Protoc Stem Cell Biol; 2014 May; 29():1C.16.1-13. PubMed ID: 24838913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hematopoietic stem cells from pluripotent stem cells: Clinical potential, challenges, and future perspectives.
    Demirci S; Leonard A; Tisdale JF
    Stem Cells Transl Med; 2020 Dec; 9(12):1549-1557. PubMed ID: 32725882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induced pluripotent stem cell technology: A window for studying the pathogenesis of acquired aplastic anemia and possible applications.
    Elbadry MI; Espinoza JL; Nakao S
    Exp Hematol; 2017 May; 49():9-18. PubMed ID: 28062362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epigenetic Variation between Human Induced Pluripotent Stem Cell Lines Is an Indicator of Differentiation Capacity.
    Nishizawa M; Chonabayashi K; Nomura M; Tanaka A; Nakamura M; Inagaki A; Nishikawa M; Takei I; Oishi A; Tanabe K; Ohnuki M; Yokota H; Koyanagi-Aoi M; Okita K; Watanabe A; Takaori-Kondo A; Yamanaka S; Yoshida Y
    Cell Stem Cell; 2016 Sep; 19(3):341-54. PubMed ID: 27476965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation of transgene-free hematopoietic stem cells from human induced pluripotent stem cells.
    Piau O; Brunet-Manquat M; L'Homme B; Petit L; Birebent B; Linard C; Moeckes L; Zuliani T; Lapillonne H; Benderitter M; Douay L; Chapel A; Guyonneau-Harmand L; Jaffredo T
    Cell Stem Cell; 2023 Dec; 30(12):1610-1623.e7. PubMed ID: 38065068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improving hematopoietic differentiation from human induced pluripotent stem cells by the modulation of Hippo signaling with a diarylheptanoid derivative.
    Thongsa-Ad U; Wongpan A; Wongkummool W; Chaiwijit P; Uppakara K; Chaiyakitpattana G; Singpant P; Tong-Ngam P; Chukhan A; Pabuprappap W; Wongniam S; Suksamrarn A; Hongeng S; Anurathapan U; Kulkeaw K; Tubsuwan A; Bhukhai K
    Stem Cell Res Ther; 2024 Mar; 15(1):60. PubMed ID: 38433217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNAs contribute to induced pluripotent stem cell somatic donor memory.
    Vitaloni M; Pulecio J; Bilic J; Kuebler B; Laricchia-Robbio L; Izpisua Belmonte JC
    J Biol Chem; 2014 Jan; 289(4):2084-98. PubMed ID: 24311783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Making a Hematopoietic Stem Cell.
    Daniel MG; Pereira CF; Lemischka IR; Moore KA
    Trends Cell Biol; 2016 Mar; 26(3):202-214. PubMed ID: 26526106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brief report: efficient generation of hematopoietic precursors and progenitors from human pluripotent stem cell lines.
    Woods NB; Parker AS; Moraghebi R; Lutz MK; Firth AL; Brennand KJ; Berggren WT; Raya A; Izpisúa Belmonte JC; Gage FH; Verma IM
    Stem Cells; 2011 Jul; 29(7):1158-64. PubMed ID: 21544903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation of engraftable hematopoietic stem cells from induced pluripotent stem cells by way of teratoma formation.
    Suzuki N; Yamazaki S; Yamaguchi T; Okabe M; Masaki H; Takaki S; Otsu M; Nakauchi H
    Mol Ther; 2013 Jul; 21(7):1424-31. PubMed ID: 23670574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ultra-High-Frequency Reprogramming of Individual Long-Term Hematopoietic Stem Cells Yields Low Somatic Variant Induced Pluripotent Stem Cells.
    Wang K; Guzman AK; Yan Z; Zhang S; Hu MY; Hamaneh MB; Yu YK; Tolu S; Zhang J; Kanavy HE; Ye K; Bartholdy B; Bouhassira EE
    Cell Rep; 2019 Mar; 26(10):2580-2592.e7. PubMed ID: 30840883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.